Open AccessMedicine

B. Furman

2021.4.1Current Protocols

DOI: 10.1002/cpz1.78

tlooto Summary

Protocols for producing STZ‐induced insulin deficiency and hyperglycemia in mice and rats and creating animal models for type 2 diabetes using STZ are described.

Abstract

Streptozotocin (STZ) is an antibiotic that causes pancreatic islet β‐cell destruction and is widely used experimentally to produce a model of type 1 diabetes mellitus (T1DM). Detailed in this article are protocols for producing STZ‐induced insulin deficiency and hyperglycemia in mice and rats. Also described are protocols for creating animal models for type 2 diabetes using STZ. These animals are employed for assessing the pathological consequences of diabetes and for screening potential therapies for the treatment of this condition. © 2021 The Authors.

Citation format

FURMAN, B. Streptozotocin‐induced diabetic models in mice and rats. Current Protocols, 2021, 1.